We present the management of the potential airway complications in a case of massive multinodular goitre treated with radioactive iodine. The patient's trachea was prophylactically intubated, using a fibreoptic technique, to prevent further airway compromise due to thyroid oedema following radioactive iodine treatment. He remained awake and intubated for five days and was extubated when there was no clinical evidence of thyroid oedema as a consequence of his treatment. This approach avoided the considerable risk of thyroidectomy in a morbidly obese patient with airway obstruction. To the authors' knowledge this approach has not been previously described.
Multinodular goitre is a relatively common condition with up to 16% of the adult population affected in non-endemic areas 1 . Whilst the majority of goitres remain asymptomatic, it is well established that massive enlargement of the thyroid gland may cause upper airway obstruction as evidenced by imaging studies and flow-volume loop curves 2 .
Whilst therapy for these massive goitres has traditionally been surgical (thyroidectomy), radioiodine (I 131 ) treatment offers a reasonable alternative for patients who are unsuitable for or decline surgical intervention [3] [4] [5] [6] . In these patients, a critical concern is protection of the airway from extrinsic compression by the thyroid gland secondary to enlargement following I 131 administration. The rate of development and the extent of this oedema will depend on several factors including the baseline size of the goitre, the initial degree of airway compression, the dose of I 131 administered and individual response to the treatment. Individual response to treatment is unpredictable and to our knowledge there is no literature to help the clinician predict the course of thyroid oedema following I 131 treatment.
We present the elective management of a patient at high risk of airway compression due to thyroid oedema following treatment of massive multinodular goitre with I 131 . We specifically discuss management of the airway.
CASE REPORT
A 45-year-old man with massive multinodular goitre was referred to the Intensive Care Unit (ICU) of Sir Charles Gairdner Hospital for review of his upper airway prior to radioiodine treatment. His thyroid disease was first noted in 1983 following a period of weight loss. In 1990 he commenced treatment with carbimazole, which was continued for three years. He became euthyroid on this regimen. At his next review in 1996, a large goitre was found on clinical examination. No imaging studies were performed at that time.
He represented on this occasion complaining of "choking" when raising his arms above his head and worsening snoring. A computed tomography (CT) scan showed a massive goitre with upper airway compression, and antithyroid treatment was recommended. Following consultation with a nuclear medicine physician, the patient, having previously rejected the option of surgical thyroidectomy, agreed to I 131 treatment in an attempt to relieve the symptoms of his goitre. An anaesthetic consultation was organized to assess his suitability for I 131 treatment and to discuss prophylactic protection of his airway which may become further compromised by thyroid oedema during this treatment.
Clinical assessment revealed a morbidly obese (195 kg), middle-aged man with a history of snoring and obstructive sleep apnoea that required nocturnal use of a continuous positive airway pressure (CPAP) mask. A sleep study performed in 1996 demonstrated 54 episodes of apnoea and hypoxaemia per hour of sleep. CPAP had been commenced at 15 cm H 2 O. Since the commencement of CPAP, daytime somnolence and morning headaches had resolved. He smoked 10 to 15 pipes/day and only consumed alcohol occasionally. Current medications were diclofenac for back pain, hydochlorthiazide and amiloride for ankle oedema, beclomethasone and pseudoephedrine for nasal blockage as well as beclomethasone and salbutamol for asthma.
Palpation of the neck resulted in the diagnosis of an extremely large goitre ( Figure 1 ) without clinically discernible retrosternal extension. There was no evidence of stridor at rest. No neck bruits were audible, nor was there any lymphadenopathy. Cardiovascular and respiratory examinations were unremarkable. The abdomen was obese, soft and non-tender. Examination of the upper airway showed a Grade 2 Mallampati 7 view and indirect laryngoscopy revealed normal function of the vocal cords.
A CT scan ( Figure 2 ) and ultrasound of his neck, were performed and demonstrated a large goitre compressing the trachea. A flow-volume loop ( Figure  3 ) was also obtained for functional dynamic assessment of his airway. This confirmed extrathoracic airway obstruction.
Following this assessment it was explained to the patient that he would be at considerable risk from life-threatening upper airway obstruction as a result of thyroid oedema following I 131 treatment. He was further advised that prophylactic protection of his airway would be warranted. An elective admission to the ICU was then arranged for airway management prior to I 131 administration. A literature search at this time did not reveal any papers providing guidance as to the extent or the time course of the thyroid oedema that could be expected. A modest initial dose of I 131 and prophylactic admission to the ICU were considered as a minimum to ensure the safety of the patient.
Awake fibreoptic nasotracheal intubation with a reinforced 8.0 mm tube was performed using topical co-phenylcaine spray and a flexible bronchoscope. The procedure was uncomplicated and the patient was able to perform self-suctioning of oral secretions following intubation. He was nursed in a designated "hot room" in the ICU for I 131 administration. Enoxaparin subcutaneously (40 mg mane) 237 and dexamethasone intravenously (8 mg four times a day) were commenced for prophylaxis against deep vein thrombosis and excessive thyroid gland swelling respectively. Oxygen was supplied at two litres/min via a heat and moisture exchanger to maintain his arterial oxygen saturation greater than 94%, and thyroid function tests were performed daily.
There was no biochemical or clinical evidence of a hyperthyroid state or thyroid swelling during his admission and his thyroid gland remained non-tender throughout.
Extubation occurred uneventfully five days following I 131 administration. The timing of extubation was entirely empirical, i.e. there was no clinical evidence of further enlargement of the thyroid as a result of oedema. Extubation was only considered after confirmation of an air leak around the endotracheal tube (with the cuff deflated and during positive pressure ventilation with a self-inflating resuscitation bag). He remained in the ICU for a further night whilst receiving CPAP to ensure patency of his airway and was then discharged to the ward on a reducing steroid regimen.
There were no major adverse consequences of his admission. However, partial obstruction of the naso-tracheal tube by inspissated secretions had slightly complicated airway management. In addition he did require treatment for sinusitis, presumably as a consequence of nasotracheal intubation, following hospital discharge (note the history of "blocked nose" prior to this admission).
DISCUSSION
As a result of the relatively rigid confines and close proximity of major structures in the neck, enlargement of the thyroid gland and treatment of this condition may incur considerable morbidity and on occasion mortality 8 . Whilst the normal adult thyroid gland weighs 20 to 25 g, massive enlargement, as may occur in multinodular goitre, can see this increased by an order of magnitude and more 9,10 . In the euthyroid state this primarily presents clinically as the 238 A. CHAKERA, P. V. VAN Treatment of the benign, enlarged, thyroid gland may be surgical or medical. Whilst surgery has been the traditional management option for patients with massively enlarged thyroid glands, surgical thyroidectomy is not without risk 13 . In addition to standard surgical complications of bleeding and infection, there are the risks of nerve damage, and vocal cord paralysis, and the possibility of inadvertent removal of the parathyroid glands, which may be embedded in the thyroid substance 8, 14 . In a patient such as ours, with multiple co-morbid medical conditions, these risks become even greater. The medical treatment aimed at reducing thyroid mass to relieve the symptoms of goitres employs radioiodine. Radioiodine is easy to administer and avoids many of the complications of surgery. The major drawbacks of radioiodine therapy are the risks of precipitating thyroid overactivity as well as thyroid oedema (which may cause upper airway obstruction), and the relatively common problem of hypothyroidism, which may develop several months to years later 3 . Additionally, the patients receiving radioiodine treatment must have their urine and faeces collected and disposed of in a safe environment and all staff made aware of the potential radiation hazard around the time of treatment.
In the absence (to our knowledge) of any other literature to provide guidance, we hope this case report sheds some light on the airway management of the patient with massive goitre, with pre-existing airway compression, who is to receive I 131 treatment. Our approach apparently provided a safe alternative to the considerable risks of thyroidectomy in this patient.
Fibreoptic techniques are well established in the management of difficult airways 15 . This case describes an important alternative strategy in the management of massive multinodular goitre, as well as highlighting one of the potential complications of long term artificial airways, i.e. obstruction by inspissated secretions.
